A phase I study of a TGF-β receptor I kinase inhibitor YL-13027 in patients with advanced solid tumors.

Jin Li,Tianshu Liu,Hanying Bao,Zusheng Xu,Yang Shu,Binghua Zheng

A phase I study of a TGF-β receptor I kinase inhibitor YL-13027 in patients with advanced solid tumors.

2021

Jin Li
Tianshu Liu
Hanying Bao
Zusheng Xu
Yang Shu
Binghua Zheng

3098Background: Transforming growth factor beta (TGF-β) is upregulated in the majority of tumors, promoting tumor cell proliferation, differentiation, and, modulation of the tumor microenvironment....

Keywords:

Medicine
Tumor microenvironment
tgf β receptors
in patient
Transforming growth factor beta
tumor cells
Downregulation and upregulation
Cancer research
Kinase
phase i study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations